PCM
MRK icon

Peregrine Capital Management’s Merck MRK Stock Holding History

Peregrine Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,954
Closed -$867K – 371
2020
Q3 		$867K Buy
+10,954
New +$858K 0.02% 258

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Peregrine Capital Management's MRK Position: Q4 2020 in Review

Peregrine Capital Management sold out of Merck (MRK) in Q4 2020, closing a stake of 10,954 shares — an estimated $867K sold.

Peregrine Capital Management first reported a position in MRK in Q3 2020 and held it in 1 quarter. The position peaked at $867K in Q3 2020. 2,708 funds tracked by Wall St. Rank hold MRK as of Q4 2020.

  • Peregrine Capital Management reported no remaining Merck position as of Q4 2020 after selling out during the quarter.
  • Peregrine Capital Management sold 10,954 Merck shares in Q4 2020, an estimated $867K.
  • Peregrine Capital Management first reported a position in Merck in Q3 2020 and held it in 1 quarter.
  • Peregrine Capital Management's Merck position peaked at $867K in Q3 2020.
  • 2,708 funds tracked by Wall St. Rank held Merck as of Q4 2020.

Based on Peregrine Capital Management's 13F filing for Q4 2020, filed 19 Jan 2021.